HomeInsights52 Week High Stocks

Lupin Ltd 52 Week High

Lupin Ltd 52 Week High

stocks purchased

₹ 3.7 Cr

Volume Transacted

(Dec 20, 2024)

stocks purchased

17.4 K

Stocks Traded

(Dec 20, 2024)

Last Updated on: Dec 22, 2024

Image

Lupin Ltd

NSE: LUPIN

YEARHIGH

₹ 2312

Last updated on: Dec 20, 2024

Key Highlights

  • The 52 Week HIGH of Lupin Ltd is ₹ 2312 as of 20 Dec 24 .

Company Fundamentals for Lupin Ltd

No data available

Market Price of Lupin Ltd

1M

1Y

3Y

5Y

Monitoring Lupin Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
20 Dec 20242147.55
19 Dec 20242162.2
18 Dec 20242098.7
17 Dec 20242045.9
16 Dec 20242062.4
13 Dec 20242075.55
12 Dec 20242117.1
11 Dec 20242149.4
10 Dec 20242134.45
09 Dec 20242106.65

Asset Value vs Market Value of Lupin Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Lupin Ltd

No data available

* All values are in crore

Historical Net Profit of Lupin Ltd

No data available

* All values are in crore

Lupin Ltd News Hub

News

Lupin receives USFDA nod for new HIV drug

Emtricitabine and tenofovir alafenamide combination is used together with other medicines ...

Read more

19 Dec 2024 09:54

News

Lupin allots 36,979 equity shares under ESOP

Lupin has allotted 36979 fully paid-up equity shares of Rs 2/- each. These shares have bee...

Read more

19 Dec 2024 16:25

News

Lupin acquires 3 anti-diabetic drugs from Boehringer Ingelheim

GIBTULIO (empagliflozin), GIBTULIO MET (empagliflozin + metformin) and AJADUO (empaglifloz...

Read more

14 Dec 2024 10:33

News

Lupin acquires 3 anti-diabetes trademarks from Boehringer Ingelheim

Lupin announced today the acquisition of anti-diabetes trademarks GIBTULIO', GIBTULIO MET'...

Read more

13 Dec 2024 18:19

News

Lupin Ltd gains for fifth session

Lupin Ltd is up for a fifth straight session in a row. The stock is quoting at Rs 2111.45,...

Read more

25 Nov 2024 13:00

News

Lupin allots 2642 equity shares under ESOP

Lupin allots 2642 equity shares under ESOP on 19 November 2024. In view of the above, the ...

Read more

19 Nov 2024 14:28

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Lupin Ltd

What is the significance of Lupin Ltd reaching its 52-week high?

Lupin Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Lupin Ltd 52-week high?

Investors monitor Lupin Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Lupin Ltd a good buy when it hits its 52-week high?

Whether Lupin Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Lupin Ltd fundamentals.

What should I consider before investing in Lupin Ltd at its 52-week high?

Before investing in Lupin Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Lupin Ltd stock price continue to rise after reaching its 52-week high?

Lupin Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions